TLR2 promotes development and progression of human glioma via enhancing autophagy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TLR2 promotes development and progression of human glioma via enhancing autophagy

Published:2019-06 Issue: Volume:700 Page:52-59
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Li Chenglong,Ma Lixin,Liu Yongliang,Li Zhenzhu,Wang Qingbo,Chen Zheng,Geng Xin,Han Xinyu,Sun Jingdong,Li Zefu

Funder

Natural Science Foundation of Shandong Province

Shandong Province

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference28 articles.

1. TLR2 and RIP2 pathways mediate autophagy of Listeria monocytogenes via extracellular signal-regulated kinase (ERK) activation;Anand;J. Biol. Chem.,2011

2. Anthoney N, Foldi I. Toll and Toll-like receptor signalling in development. 2018; 145:

3. Liquid biopsies in patients with diffuse glioma;Best;Acta Neuropathol.,2015

4. TLR2 mediates phagocytosis and autophagy through JNK signaling pathway in Staphylococcus aureus-stimulated RAW264.7 cells;Fang;Cell. Signal.,2014

5. Enhanced combination therapy effect on paclitaxel-resistant carcinoma by chloroquine co-delivery via liposomes;Gao;Int. J. Nanomedicine,2015

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual perspective on autophagy in glioma: Detangling the dichotomous mechanisms of signaling pathways for therapeutic insights;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Clinical significance of immune-related antigen CD58 in gliomas and analysis of its potential core related gene clusters;Heliyon;2024-04

3. Harnessing innate immune pathways for therapeutic advancement in cancer;Signal Transduction and Targeted Therapy;2024-03-25

4. TLR AND CANCER: THE ENIGMATIC CROSS TALK;Thirty Years since the Discovery of Toll-Like Receptors;2024-03-20

5. Dysregulation of inflammasome activation in glioma;Cell Communication and Signaling;2023-09-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3